15 january 14:15–15:00
Expert Discussion

NO PROTECTION, NO INNOVATION. WAYS TO PROTECT INTELLECTUAL PROPERTY RIGHTS IN RELATION TO MEDICINES

 Matrix Studio
Moderator:
Alexander Plakida, Executive Director, Effective Healthcare Platform; Managing Director, Alliance Consulting
Panellists:
Grigory Ivliev, Head of Federal Service for Intellectual Property (Rospatent)
Shannon Klinger, Chief Legal Officer Novartis AG
Victor Fisenko, Deputy Minister of Health of the Russian Federation
Protection of intellectual property rights is the basis for development of innovations in the field of pharmaceuticals. Many years of international experience show that breakthrough technologies and effective protection of intellectual property are the precondition for the country reaching a qualitatively new level, both in order to ensure sustainable development of its own healthcare system and pharmaceutical industry, and in its integration into the international pharmaceutical market.
Intellectual rights, like any other legal instrument, have a number of specifics such as, for example, protection of patents or securing protection of clinical research data, which require per-point balancing and adjustment. And even when the legislation becomes fully compliant with all the "best world practices", law enforcement can severely "lag behind".

Issues for discussion:
•How to ensure law enforcement to be a catalyst, rather than a barrier, for innovation development?
•How to harmonize the countries’ approaches in this matter in the single pharmaceutical market of the EAEU?
Top